Correlation of hyperprolactinemia, Subclinical hypothyroidism with Polycystic Ovary Syndrome and infertility


Background: Polycystic ovarian syndrome (PCOS) is a hyperandrogenic condition characterized by polycystic ovarian morphology and chronic oligo-anovulation.  When it is combines with hypothyroidism and hyperprolactinemia, this condition can have severe consequences, may even lead to infertility.

Case Presentation: This case study illustrates the complexity of PCOS and the significance of a multidisciplinary approach to its diagnosis and therapy. The patient is a 24-year-old non diabetic nonsmoker female with PCOS who has been attempting to conceive for seven years. The patient presented to the hospital with irregular menstrual cycles and a desire to become pregnant. The patient had previously been unsuccessfully treated with Clomid and letrozole. The patient's BMI was determined to be 23. 3 and a pelvic scan indicated PCO ovaries. Laboratory results revealed
hyperprolactinemia (53 ng/ml) and subclinical hypothyroidism (TSH 12.6 uIU/ml, T4 0.54 ng/dL- TPO
antibodies:187 IU/mL, Anti thyroglobulin antibodies 235 IU/mL), but a pituitary gland MRI was normal. Thyroid US features going with Hashimoto thyroiditis. The patient's PCOS symptoms were initially managed with metformin and Duphaston, and then Cabergoline was introduced to address hyperprolactinemia. The patient became pregnant shortly following hyperprolactinemia medication. Prenatal screenings revealed elevated fasting glucose levels and gestational diabetes. The patient's blood sugar was initially controlled by Metformin, but she later required multiple insulin doses to maintain control.  The patient was scheduled for induction of labor at 38 weeks, but a lower segment emergency cesarean surgery was performed due to fetal distress.

Conclusion: Regular monitoring and management of both PCOS and related conditions such as hypothyroidism and hyperprolactinemia are crucial to ensure the best outcome for the patient. Additionally, we suggest Metformin, Duphaston, Cabergoline to treat PCOS patient having subclinical hypothyroidism and hyperprolactinemia.

Keywords: Polycystic ovarian syndrome, subclinical hypothyroidism, hyperprolactinemia, gestational diabetes.

Keywords: Polycystic ovarian syndrome, subclinical hypothyroidism, hyperprolactinemia, gestational diabetes


Download data is not yet available.

Author Biographies

Asha Abu Baker Badawei, Obstetrics and Gynecology Department, Cure Plus Medical Center (CPMC), AL Ain, UAE

Obstetrics and Gynecology Department, Cure Plus Medical Center (CPMC), AL Ain, UAE

Ashraf ALakkad, Internal Medicine Department, Madinat Zayed Hospital, AL Dhafra, UAE

Internal Medicine Department, Madinat Zayed Hospital, AL Dhafra, UAE

Rania Murad, Endocrinology Department, Cure Plus Medical Center (CPMC), AL Ain, UAE

Endocrinology Department, Cure Plus Medical Center (CPMC), AL Ain, UAE


1. Nath CK, Barman B, Das A, Rajkhowa P, Baruah P, Baruah M, et al. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India. J Family Med Prim Care. 2019; 8(1):256-60.
2. Peddemul A, Tejovath S, Hassan D, K KP, Sikandar R, Kahlon SS, et al. Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review. Cureus. 2022; 14(8):e28468.
3. Deswal R, Nanda S, Dang AS. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome. Systems Biology in Reproductive Medicine. 2019; 65(5):400-8.
4. Khattak M, Sultana N, Usman R, Khattak U, Zafar U, Salman H. Luteinizing hormone to follicle stimulating hormone ratio in patients with polycystic ovary syndrome. Journal of Ayub Medical College Abbottabad. 2020; 32(2):255-8.
5. Hsu M-I. Changes in the PCOS phenotype with age. Steroids. 2013; 78(8):761-6.
6. Zeng X, Xie Y-j, Liu Y-t, Long S-l, Mo Z-c. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clinica chimica acta. 2020; 502:214-21.
7. Nayak PK, Mitra S, Sahoo J, Mahapatra E, Agrawal S, Lone Z. Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients. Journal of family medicine and primary care. 2020; 9(1):147.
8. Fatima M, Amjad S, Ali Sr HS, Ahmed T, Khan S, Raza M, et al. Correlation of subclinical hypothyroidism with polycystic ovary syndrome (PCOS). Cureus. 2020; 12(5).
9. Bonakdaran S, Milani N, Mazloumkhorasani Z, Hosseinzadeh M, Kabiri M. Is There a Relation between Hypothyroidism and Polycystic Ovary Syndrome and its Metabolic Components? Current Diabetes Reviews. 2022.
10. Kumar S, Kotur P. Effects of hypothyroidism in Indian women of reproductive age group-A review. Indian Journal of Obstetrics and Gynecology Research. 2020; 7(1):1-6.
11. Thapa S, Bhusal K. Hyperprolactinemia. StatPearls [Internet]: StatPearls Publishing; 2021.
12. Delcour C, Robin G, Young J, Dewailly D. PCOS and Hyperprolactinemia: what do we know in 2019? Clinical Medicine Insights: Reproductive Health. 2019; 13:1179558119871921.
13. Aldahmani K, AlMalki M, Beshyah S. A rational approach to the evaluation and management of patients with hyperprolactinemia. Ibnosina Journal of Medicine and Biomedical Sciences. 2020; 12(02):90-7.
14. Pekić S, Stojanoska MM, Popovic V. Hyperprolactinemia/prolactinomas in the postmenopausal period: challenges in diagnosis and management. Neuroendocrinology. 2019; 109(1):28-33.
15. Michail M, Ioannis K, Charoula M, Alexandra T, Eleftheria H. Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review. Acta Bio Medica: Atenei Parmensis. 2019; 90(1):149.
16. Franks S, Hardy K. What causes anovulation in polycystic ovary syndrome? Current Opinion in Endocrine and Metabolic Research. 2020; 12:59-65.
17. Abinaya S, Siva D, Sabitha R, Achiraman S. An overview of hyperandrogenism in PCOS and the prospective underlying factors. Res J Life Sci Bioinform Pharmac Chem Sci. 2019; 1(5):179-86.
18. Ahtamovna ZZ. Secondary infertility in women of reproductive age with hypothyroidism. ACADEMICIA: An International Multidisciplinary Research Journal. 2022; 12(5):649-53.
19. Hasegawa Y, Kitahara Y, Osuka S, Tsukui Y, Kobayashi M, Iwase A. Effect of hypothyroidism and thyroid autoimmunity on the ovarian reserve: A systematic review and meta‐analysis. Reproductive Medicine and Biology. 2022; 21(1):e12427.
20. Ansari MS, Almalki MH. Primary hypothyroidism with markedly high prolactin. Frontiers in Endocrinology. 2016; 7:35.
21. Gierach M, Bruska-Sikorska M, Rojek M, Junik R. Hyperprolactinemia and insulin resistance. Endokrynologia Polska. 2022.
22. Saei Ghare Naz M, Mousavi M, Mahboobifard F, Niknam A, Ramezani Tehrani F. A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome. Diagnostics. 2022; 12(12):2924.
23. Filho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol. 2007; 23(5):267-72.
24. Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Human Reproduction. 2020; 35(7):1666-74.
25. Meng J, Zhu Y. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 257:19-24.
26. Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Scientific reports. 2020; 10(1):1-13.
27. Guan Y, Wang D, Bu H, Zhao T, Wang H. The effect of metformin on polycystic ovary syndrome in overweight women: a systematic review and meta-analysis of randomized controlled trials. International journal of endocrinology. 2020; 2020.
332 Views | 57 Downloads
How to Cite
Badawei AAB, ALakkad A, Murad R. Correlation of hyperprolactinemia, Subclinical hypothyroidism with Polycystic Ovary Syndrome and infertility. JDDT [Internet]. 15Mar.2023 [cited 1Dec.2023];13(3):1-. Available from: